BridgeBio has significantly boosted the course of the new therapy for amyloid heart disease, leveraging Attruby. Initial trial data suggests promising benefits for those suffering with a debilitating disease. The emphasis represents BridgeBio's commitment to treating significant healthcare needs in a cardiology space. Attruby: BridgeBio's Novel Ap